74 related articles for article (PubMed ID: 8731830)
1. [A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
Li J; Miao J; Hu W
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):680-2. PubMed ID: 8731830
[TBL] [Abstract][Full Text] [Related]
2. [A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS].
Li J; Zhu Y; Hu W
Zhonghua Nei Ke Za Zhi; 1996 Dec; 35(12):819-23. PubMed ID: 9592308
[TBL] [Abstract][Full Text] [Related]
3. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
4. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
[TBL] [Abstract][Full Text] [Related]
5. [Sulperazone in the treatment of severe infections in patients with cancer].
Mitrokhin SD
Antibiot Khimioter; 2003; 48(3):26-9. PubMed ID: 12914118
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
[TBL] [Abstract][Full Text] [Related]
7. [Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections].
Iakovlev VP; Blatun LA; Puchkova LS; Svetukhin AM
Antibiot Khimioter; 1994 Dec; 39(12):31-4. PubMed ID: 7733785
[TBL] [Abstract][Full Text] [Related]
8. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
Kawamura J; Hayashi N; Okabe S; Kawahara S; Chigusa I; Araki T; Saito K; Takeno K; Suzuki N; Suzuki I
Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Kochhar P; Suvarna V; Duttagupta S; Sarkar S
Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
[TBL] [Abstract][Full Text] [Related]
10. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
11. [Sulperazone--a combined form of cefoperazone with sulbactam].
Iakovlev VP
Antibiot Khimioter; 1995 Feb; 40(2):55-70. PubMed ID: 7605145
[No Abstract] [Full Text] [Related]
12. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
13. Use of cefoperazone/sulbactam in neonates.
Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
[TBL] [Abstract][Full Text] [Related]
14. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
Reddy J
N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Huang JJ; Zeng Q; Yu JL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital.
Koomanachai P; Tongsai S; Thamlikitkul V
J Med Assoc Thai; 2016 Jan; 99(1):8-14. PubMed ID: 27455819
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
Oyabu Y
Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
[TBL] [Abstract][Full Text] [Related]
18. [Use of sulperazone in acute surgical conditions].
Grosmanová T; Klementa I; Král V; Kolár M
Bratisl Lek Listy; 1999 Dec; 100(12):709-11. PubMed ID: 10847756
[TBL] [Abstract][Full Text] [Related]
19. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
[TBL] [Abstract][Full Text] [Related]
20. [Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
Antibiot Khimioter; 2006; 51(1):14-7. PubMed ID: 16734360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
